Search - tctmd.com

Displaying 141 - 160 of 825

Sort: Relevancy | Date

Ukrainian Physicians Like Me Want to Get Back to Doctoring, but Barriers Are Many

News Opinion Off Script

Ukrainian Physicians Like Me Want to Get Back to Doctoring, but Barriers Are Many

Oksana Marchenko, MD

December 07, 2023

New AF Guideline Emphasizes Early Rhythm Control, Elevates Ablation and LAAO

News Daily News

New AF Guideline Emphasizes Early Rhythm Control, Elevates Ablation and LAAO

November 30, 2023

Symplicity Spyral Approved: FDA Clears Second Renal Denervation System

News Daily News

Symplicity Spyral Approved: FDA Clears Second Renal Denervation System

November 20, 2023

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

November 12, 2023

New Carotid Stent Systems Associated With Low Stroke Risk

News Conference News VIVA 2023

New Carotid Stent Systems Associated With Low Stroke Risk

November 09, 2023

FDA Approves Paradise Renal Denervation System: What Comes Next?

News Daily News

FDA Approves Paradise Renal Denervation System: What Comes Next?

November 08, 2023

What’s Going to Be Hot at AHA 2023

News Opinion Editor's Corner AHA 2023

What’s Going to Be Hot at AHA 2023

November 07, 2023

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

News Conference News VIVA 2023

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

November 01, 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

October 25, 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

October 24, 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Sham Procedures in CV Research: What’s Sacrificed for Science?

News Daily News

Sham Procedures in CV Research: What’s Sacrificed for Science?

October 23, 2023

What’s Going to Be Hot at TCT 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

October 19, 2023

FDA Scolds Abiomed for Not Seeking a PMA for Its Web-Based User Portal

News Daily News

FDA Scolds Abiomed for Not Seeking a PMA for Its Web-Based User Portal

October 17, 2023

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

News Conference News HFSA 2023

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

Yael L. Maxwell

October 16, 2023

PA Pressure Monitoring Benefits HF Patients With No Recent Hospitalization

News Conference News HFSA 2023

PA Pressure Monitoring Benefits HF Patients With No Recent Hospitalization

October 12, 2023

October 2023 News Roundup

News Opinion CV Team Dispatch

October 2023 News Roundup

October 01, 2023

FDA Approves Blood Flow-Diverting LimFlow System for No-Option CLTI

News Daily News

FDA Approves Blood Flow-Diverting LimFlow System for No-Option CLTI

September 12, 2023

AHA, AMA Make Call for Enhanced Efforts to Control Americans’ BP

News Daily News

AHA, AMA Make Call for Enhanced Efforts to Control Americans’ BP

September 07, 2023

September 2023 News Roundup

News Opinion CV Team Dispatch

September 2023 News Roundup

September 01, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.